Amended Statement of Beneficial Ownership (3/a)
05 November 2022 - 8:55AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Freeman Jeffrey Brennan |
2. Date of Event Requiring Statement (MM/DD/YYYY)
10/25/2022
|
3. Issuer Name and Ticker or Trading Symbol
Inotiv, Inc. [NOTV]
|
(Last)
(First)
(Middle)
2701 KENT AVENUE |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) VP-Finance & Corp. Controller / |
(Street)
WEST LAFAYETTE, IN 47906-1382
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY) 11/4/2022
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 675 (1) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Employee Stock Option (right to buy) | (2) | 10/15/2031 | Common Stock | 2000 | $34.69 | D | |
Explanation of Responses: |
(1) | Represents restricted stock units, 568 of which vest in full on October 22, 2023 and 107 of which vest in full on December 17, 2023, subject to continued employment. |
(2) | The stock option becomes exercisable with respect to 800 shares on October 15, 2022, 600 shares on October 15, 2023 and 600 shares on October 15, 2024, subject to continued employment. |
Remarks: This amendment is being filed solely to attach the Power of Attorney in the correct format. Exhibit 24 - Power of Attorney |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Freeman Jeffrey Brennan 2701 KENT AVENUE WEST LAFAYETTE, IN 47906-1382 |
|
| VP-Finance & Corp. Controller |
|
Signatures
|
Jeffrey Brennan Freeman | | 11/4/2022 |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bioanalytical Systems Inc (NASDAQ): 0 recent articles
More Inotiv, Inc. News Articles